Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Pulsipher

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Bone Marrow Transplantation|December 21, 2004
Safety and efficacy of allogeneic PBSC collection in normal pediatric donors: the pediatric blood and marrow transplant consortium experience (PBMTC) 1996-2003M A Pulsipher, J E Levine, R J Hayashi, et al.
Bone Marrow Transplantation|January 11, 2005
Stem cell transplantation in patients with severe congenital neutropenia with evidence of leukemic transformationS W Choi, L A Boxer, M A Pulsipher, et al.
Bone Marrow Transplantation|June 29, 2010
Treatment of Fanconi anemia patients using fludarabine and low-dose TBI, followed by unrelated donor hematopoietic cell transplantationM S Thakar, P Kurre, R Storb, et al.
Bone Marrow Transplantation|August 2, 2016
Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GvHD?S Gallo, A E Woolfrey, L M Burroughs, et al.
Bone Marrow Transplantation|May 12, 2015
Risk factors and timing of relapse after allogeneic transplantation in pediatric ALL: for whom and when should interventions be tested?M A Pulsipher, B Langholz, D A Wall, et al.
Bone Marrow Transplantation|May 21, 2008
Donor leukocyte infusions to treat hematologic malignancy relapse following allo-SCT in a pediatric populationJ E Levine, A J Barrett, M-J Zhang, et al.
Bone Marrow Transplantation|June 27, 2017
Parent versus child donor perceptions of the bone marrow donation experienceG E Switzer, J Bruce, G Pastorek, et al.
Bone Marrow Transplantation|March 29, 2011
Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDSS M Luger, O Ringdén, M-J Zhang, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Bone Marrow Transplantation|December 21, 2004
Safety and efficacy of allogeneic PBSC collection in normal pediatric donors: the pediatric blood and marrow transplant consortium experience (PBMTC) 1996-2003M A Pulsipher, J E Levine, R J Hayashi, et al.
Bone Marrow Transplantation|January 11, 2005
Stem cell transplantation in patients with severe congenital neutropenia with evidence of leukemic transformationS W Choi, L A Boxer, M A Pulsipher, et al.
Bone Marrow Transplantation|June 29, 2010
Treatment of Fanconi anemia patients using fludarabine and low-dose TBI, followed by unrelated donor hematopoietic cell transplantationM S Thakar, P Kurre, R Storb, et al.
Bone Marrow Transplantation|August 2, 2016
Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GvHD?S Gallo, A E Woolfrey, L M Burroughs, et al.
Bone Marrow Transplantation|May 12, 2015
Risk factors and timing of relapse after allogeneic transplantation in pediatric ALL: for whom and when should interventions be tested?M A Pulsipher, B Langholz, D A Wall, et al.
Bone Marrow Transplantation|May 21, 2008
Donor leukocyte infusions to treat hematologic malignancy relapse following allo-SCT in a pediatric populationJ E Levine, A J Barrett, M-J Zhang, et al.
Bone Marrow Transplantation|June 27, 2017
Parent versus child donor perceptions of the bone marrow donation experienceG E Switzer, J Bruce, G Pastorek, et al.
Bone Marrow Transplantation|March 29, 2011
Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDSS M Luger, O Ringdén, M-J Zhang, et al.
Pageof 2